Institute for Molecular Biology and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria; Tyrolean Cancer Research Institute (TKFI), Innsbruck, Austria
Institute for Molecular Biology and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria; Tyrolean Cancer Research Institute (TKFI), Innsbruck, Austria
Andreas Feichtner
Institute for Molecular Biology and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria; Tyrolean Cancer Research Institute (TKFI), Innsbruck, Austria
Florian Enzler
Daniel Swarovski Research Laboratory, Department of Visceral, Transplant and Thoracic Surgery, Medical University of Innsbruck, Innsbruck, Austria
Jakob Fleischmann
Institute for Molecular Biology and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria; Tyrolean Cancer Research Institute (TKFI), Innsbruck, Austria
Sophie Strich
Institute for Molecular Biology and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria; Tyrolean Cancer Research Institute (TKFI), Innsbruck, Austria
Sarah Schwarz
Tyrolean Cancer Research Institute (TKFI), Innsbruck, Austria
Rebecca Wilson
The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom
Philipp Tschaikner
Tyrolean Cancer Research Institute (TKFI), Innsbruck, Austria; KinCon biolabs GmbH, Innsbruck, Austria
Jakob Troppmair
Daniel Swarovski Research Laboratory, Department of Visceral, Transplant and Thoracic Surgery, Medical University of Innsbruck, Innsbruck, Austria
Institute for Molecular Biology and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck, Austria; Tyrolean Cancer Research Institute (TKFI), Innsbruck, Austria; KinCon biolabs GmbH, Innsbruck, Austria
Protein kinases act as central molecular switches in the control of cellular functions. Alterations in the regulation and function of protein kinases may provoke diseases including cancer. In this study we investigate the conformational states of such disease-associated kinases using the high sensitivity of the kinase conformation (KinCon) reporter system. We first track BRAF kinase activity conformational changes upon melanoma drug binding. Second, we also use the KinCon reporter technology to examine the impact of regulatory protein interactions on LKB1 kinase tumor suppressor functions. Third, we explore the conformational dynamics of RIP kinases in response to TNF pathway activation and small molecule interactions. Finally, we show that CDK4/6 interactions with regulatory proteins alter conformations which remain unaffected in the presence of clinically applied inhibitors. Apart from its predictive value, the KinCon technology helps to identify cellular factors that impact drug efficacies. The understanding of the structural dynamics of full-length protein kinases when interacting with small molecule inhibitors or regulatory proteins is crucial for designing more effective therapeutic strategies.